Search results

ANSTO researchers contribute to study which finds evidence of Aboriginal occupation 65,000 years ago in Northern Australia.

Seven of Australia’s top nuclear medicine professionals have been briefed on ANSTO’s plans to manage radioactive waste, as well as to support nuclear medicine innovation in Australia.

Australian scientists from ANTSO have congratulated their British colleagues for a major advance in their quest to develop practical nuclear fusion.

Today The Australian ran a story entitled “Fears for indigenous lands as foreign nuclear waste headed our way”, 18 September 2018. ANSTO was not contacted in relation to the article, but can provide the following information in response which can be attributed to a spokesperson.

Information about ANSTO’s COVID-19 Rapid Antigen Test Program

A special inaugural event held by ANSTO at its Australian Synchrotron for more than 30 funding organisations has showcased the first of the $100 million BRIGHT Program’s brand new, state-of-the-art beamlines.

ANSTO renewed its Memorandum of Understanding (MOU) with the Japan Proton Accelerator Research Complex (J-PARC) operated by the High Energy Accelerator Research Organisation (KEK) and Japan Atomic Energy Agency (JAEA). Now broadened to include their partner Comprehensive Research Organization for Science and Society (CROSS), the signing took place early in the year and a celebratory workshop was held late July.

ANSTO has contributed to research on a novel therapeutic option for combatting antimicrobial-resistant Gram-negative bacteria, known as superbugs.

Lithium Australia, a company that has a close association with ANSTO’s business unit Minerals, has been awarded a US patent for its unique lithium mining technology SiLeach®.

A long-standing collaboration led biomedical researchers from the University of Sydney has recently achieved success with the recent announcement of an innovative bone implant that significantly reduces rejection and inflammation.